Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Immunomodulation by interleukin-2 receptor targeted therapy

D Gupta¹, S Naik

¹Sanjay Gandhi Postgraduate Institute of Medical Sciences, Uttar Pradesh, India.

The National Medical Journal of India

|March 1, 1994

Summary

Targeting the interleukin-2 receptor (IL-2R) offers a novel immunosuppression strategy. Anti-IL-2R therapies selectively eliminate activated lymphocytes implicated in autoimmune diseases and cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prevalence of Aspergillus sensitisation in pulmonary tuberculosis-related fibrocavitary disease.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2014

Same author

Expression of short chain fatty acid receptors and pro-inflammatory cytokines in utero-placental tissues is altered in cows developing retention of fetal membranes.

Placenta·2014

Same author

Adaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcome.

The British journal of radiology·2014

Same author

Intradescemetic air trap post deep anterior lamellar keratoplasty in a child with mucopolysaccharidosis.

Eye (London, England)·2014

Same author

Role of surgical staging and adjuvant treatment in uterine serous carcinoma.

European journal of gynaecological oncology·2014

Same author

Inter-character relationships and heterosis observed in opaque-2 maize crosses and in their normal analogues.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2014

Area of Science:

Immunology
Oncology
Transplantation

Background:

The interleukin-2 receptor (IL-2R) is a key marker on activated T-lymphocytes.
IL-2R-expressing lymphocytes infiltrate tissues in autoimmune conditions like rheumatoid arthritis and diabetes, as well as in various hematologic malignancies.
These include Hodgkin's disease, leukaemias, and lymphomas.

Purpose of the Study:

To evaluate the therapeutic potential of targeting the IL-2R for selective immunosuppression.
To assess the safety and efficacy of anti-IL-2R therapies in autoimmune diseases and cancers.

Main Methods:

Utilizing anti-IL-2R monoclonal antibodies and chimeric IL-2R toxins for targeted cell elimination.
Employing experimental models for autoimmunity and transplantation studies.
Conducting open, uncontrolled clinical trials in patients with refractory conditions.

Main Results:

Experimental models demonstrated beneficial results in autoimmunity and transplantation, indicating effective selective immunosuppression.
Chimeric IL-2R toxin proved safe and effective in patients with refractory rheumatoid arthritis and insulin-dependent diabetes mellitus.
The therapy was also effective in patients with IL-2R-bearing leukaemias and lymphomas.

Conclusions:

Targeting the IL-2R represents a promising approach for selective immunosuppression in autoimmune diseases.
Anti-IL-2R therapies offer a viable treatment strategy for specific hematologic malignancies.
Chimeric IL-2R toxins show significant safety and efficacy in refractory conditions, warranting further investigation.

Related Experiment Videos